• OPEN AN ACCOUNT
Indian Indices
Sensex
77,472.94 -183.15
( -0.24%)
Global Indices
Nasdaq
53,487.87 -110.53
(-0.21%)
Dow Jones
7,697.38 -0.90
(-0.01%)
Hang Seng
66,269.23 412.80
(0.63%)
Nikkei 225
10,888.36 2.20
(0.02%)
Forex
USD-INR
95.70 0.06
(0.07%)
EUR-INR
111.67 0.01
(0.01%)
GBP-INR
130.50 0.05
(0.04%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
15.13
100188.79
EPS(TTM)
Face Value()
Div & Yield %
144.82
2
0.82
 

Gillanders Arbuthnot & Company reports consolidated net loss of Rs 3.89 crore in the March 2026 quarter
May 11,2026
Net loss of Gillanders Arbuthnot & Company reported to Rs 3.89 crore in the quarter ended March 2026 as against net profit of Rs 2.04 crore during the previous quarter ended March 2025. Sales declined 0.53% to Rs 103.39 crore in the quarter ended March 2026 as against Rs 103.94 crore during the previous quarter ended March 2025.

For the full year,net profit declined 64.56% to Rs 9.47 crore in the year ended March 2026 as against Rs 26.72 crore during the previous year ended March 2025. Sales declined 2.78% to Rs 430.87 crore in the year ended March 2026 as against Rs 443.18 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales103.39103.94 -1 430.87443.18 -3
OPM %-4.22-2.00 -5.425.80 -
PBDT-2.13-1.11 -92 22.0023.89 -8
PBT-4.92-3.71 -33 11.0813.03 -15
NP-3.892.04 PL 9.4726.72 -65